Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
17 studies found for:    Corticobasal Degeneration
Show Display Options
RSS Create an RSS feed from your search for:
Corticobasal Degeneration
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Drug: Lithium
2 Completed Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration;   Parkinsonism
Intervention:
3 Recruiting Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Interventions: Drug: 18F-AV-1451;   Drug: florbetapir F18
4 Recruiting 4 Repeat Tauopathy Neuroimaging Initiative
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Other: Observational Study
5 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
6 Active, not recruiting Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders, PD,Essential Tremor, (ET),Cortical Basal Degeneration, (CBD),Multiple Systems Atrophy (MSA), Magnetoencephalography
Conditions: Essential Tremor;   Multiple System Atrophy;   Corticobasal Degeneration;   Supranuclear Palsy, Progressive
Intervention:
7 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
8 Recruiting Safety Study of TPI-287 to Treat CBS and PSP
Conditions: Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
Interventions: Drug: TPI 287  2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2
9 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment;   REM Sleep Behavior Disorder
Interventions: Drug: I-123 Ioflupane solution injection prior to SPECT scan (DaTscan);   Device: Single photon emission computed tomography (SPECT) scan
10 Completed Effects of Coenzyme Q10 in PSP and CBD
Conditions: Progressive Supranuclear Palsy;   Neurological Disorders
Intervention: Drug: CoQ10
11 Completed The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
Condition: Parkinson's Disease
Intervention: Drug: 18F-FDG
12 Recruiting Study for the Early Diagnosis of Parkinson's Disease
Condition: Parkinson's Disease, Idiopathic
Intervention:
13 Active, not recruiting Parkinson's Disease, Diagnostic Observations (PADDO)
Conditions: Parkinson's Disease;   Atypical Parkinsonism
Intervention:
14 Unknown  Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized
Condition: Alzheimer's Disease
Intervention:
15 Completed Study of Tongue Pressures
Conditions: Deglutition Disorder;   Healthy
Intervention:
16 Active, not recruiting The Sunnybrook Dementia Study: Mapping Brain Changes in Alzheimer's, Vascular and Other Dementias
Condition: Dementia
Intervention:
17 Completed Electrical Polarization of the Brain in Corticobasal Syndrome
Condition: Corticobasal Syndrome
Intervention: Device: Phoresor II

Indicates status has not been verified in more than two years